Do you know the feeling of product loss?
For More Information
RoSS® // Robust Storage and Shipping for all single use bags
Liquid bulk drug substance is of utmost value after manufacturing from Biopharma industries. The single-use bag independent platform RoSS® helps to avoid product loss through breakages through robust composition and makes it possible to introduce your flexible end-to-end solution in drug substance logistics.
Watch Video
Case study: Product Loss Cost efficiency
Biopharmaceutical companies have largely accepted a certain level of product loss when managing drug substances in single-use systems - unaware that solutions exist to streamline process steps and dramatically diminish product loss. A global biotechnology company’s goal was to reduce the current product loss below 0.5%
Download
Case study: Product Loss Bag independence
The choice of single-use bioprocess containers in biopharmaceutical handling has had consequences for the performance and requirements in biomanufacturing until now. Lack of compatibility and inflexibility of platform systems have determined future investments. A global CDMO has set its goal to find single-use bag-independent solutions to increase process flexibility whilst minimizing product loss rate.
Download
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
May 14th 2025Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
